Page last updated: 2024-11-04

1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Cancer of the Thyroid

1,4-bis(2-(3,5-dichloropyridyloxy))benzene has been researched along with Cancer of the Thyroid in 2 studies

1,4-bis(2-(3,5-dichloropyridyloxy))benzene: potent phenobarbital-like inducer of microsomal monooxygenase activity; structure given in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qatanani, M1
Zhang, J1
Moore, DD1
Diwan, BA1
Henneman, JR1
Rice, JM1
Nims, RW1

Other Studies

2 other studies available for 1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Cancer of the Thyroid

ArticleYear
Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism.
    Endocrinology, 2005, Volume: 146, Issue:3

    Topics: Animals; Anticonvulsants; Blotting, Northern; Cell Proliferation; Constitutive Androstane Receptor;

2005
Enhancement of thyroid and hepatocarcinogenesis by 1,4-bis[2-(3,5- dichloropyridyloxy)]benzene in rats at doses that cause maximal induction of CYP2B.
    Carcinogenesis, 1996, Volume: 17, Issue:1

    Topics: Animals; Carcinogens; Cytochrome P-450 Enzyme System; Diethylnitrosamine; Enzyme Induction; Liver Ne

1996